Naringin

DB16859ExperimentalSmall molecule

Naringin: Overview.

Mechanism: Pharmacologically active on Nitric oxide synthase, inducible, Carbonic anhydrase 2, and 3-hydroxy-3-methylglutaryl-coenzyme A reductase
Curator reviewed
Formula / weight: C₂₇H₃₂O₁₄ · 580.539 g/mol (avg)
Code names: AI3-19008

Resolves to

Compound

Clinical / RWD

Structure

[H][C@@]1(O[C@@H]2[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]2OC2=CC3=C(C(=O)C[C@H](O3)C3=CC=C(O)C=C3)C(O)=C2)O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O

Targets

Transporters

What you can answer from here — as of September 21, 2026

11Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

3TransportersSubstrate / inhibitor direction, not just membership

Listed above

19+ReferencesStructured and connected to the statements they support

Which drugs share a target with Naringin, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.